Alkermes (ALKS) Retained Earnings (2011 - 2026)

Alkermes' (ALKS) quarterly Retained Earnings came in at -$801.3 million in Q1 2026, down 54970.38% year-on-year from N/an in Q1 2025, and down 38055.9% on a QoQ basis from -$2.1 million in Q4 2025.

Alkermes (ALKS) Retained Earnings (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 16 years of Retained Earnings data on file, last reported at -$801.3 million in Q1 2026.

  • On a quarterly basis, Retained Earnings fell 54970.38% year-over-year to -$801.3 million in Q1 2026; TTM through Mar 2026 was -$801.3 million, a 54970.38% decrease from a year earlier, with the FY2025 full-year figure at -$2.1 million, down 6.76% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$801.3 million, down from -$2.1 million in the prior quarter.
  • Over the last five years, Retained Earnings for ALKS reached as high as $425000.0 in Q3 2024 and fell as low as -$1.6 billion in Q2 2022.
  • Historically, Retained Earnings has averaged -$474.7 million across 5 years, with a median of -$8.2 million in 2022.
  • Across the five-year window, Retained Earnings surged 100.03% in 2024 and tumbled 54970.38% in 2026, its largest moves.
  • Year by year, Retained Earnings stood at -$10.9 million in 2022, then slumped by 12238.4% to -$1.3 billion in 2023, then surged by 99.85% to -$2.0 million in 2024, then slipped by 6.76% to -$2.1 million in 2025, then slumped by 38055.9% to -$801.3 million in 2026.
  • Per Business Quant data, the three most recent Retained Earnings figures were -$801.3 million in Q1 2026, -$2.1 million in Q4 2025, and -$1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 37.04 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 28.20 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.11 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.54 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 8.83 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -1.81 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 18.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 589.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.13 Bn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn -801.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -801.27 Mn
Dec 31, 2025 -2.10 Mn
Sep 30, 2025 -1.06 Mn
Jun 30, 2025 -1.40 Mn
Mar 31, 2025 -1.46 Mn
Dec 31, 2024 -1.97 Mn
Sep 30, 2024 425,000.00
Jun 30, 2024 -3.59 Mn
Mar 31, 2024 -1.31 Bn
Dec 31, 2023 -1.34 Bn
Sep 30, 2023 -1.46 Bn
Jun 30, 2023 -1.50 Bn
Mar 31, 2023 -8.13 Mn
Dec 31, 2022 -10.89 Mn
Sep 30, 2022 -12.84 Mn
Jun 30, 2022 -1.61 Bn
Mar 31, 2022 -8.23 Mn
Dec 31, 2021 -3.72 Mn
Sep 30, 2021 -2.47 Mn
Jun 30, 2021 -1.51 Bn